Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the future

By sjmartinez • October 31, 2024

Adam SJ, Buchman TG, Currier JS, Draghia-Akli R, Fessel JP, Higgs ES, Hughes EA, LaVange L, Menetski JP, Read SW, Rosenberg Y, Tressler R; ACTIV Therapeutics-Clinical Working Group. Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the future. J Clin Transl Sci. 2024 Oct 15;8(1):e150. doi: 10.1017/cts.2024.178. PMID: 39478782; PMCID: PMC11523022.

Tags: covid-19, Infectious Diseases, lessons learned, master protocol, Publications, Therapeutics, trials

A spatial transcriptomic atlas of the host response to oropharyngeal candidiasis

Nabeela S, McSwiggin H, Magalhaes RDM, Mattos EC, Mannan M, Dillon JT, Barbarino A, Youssef EG, Singh S, Yan W, Ibrahim AS, Conti HR, Uppuluri[...]

Strain background interacts with chromosome 7 aneuploidy to determine commensal and virulence phenotypes in Candida albicans

Mishra A, Solis NV, Dietz SM, Crouch AL, Filler SG, Anderson MZ. Strain background interacts with chromosome 7 aneuploidy to determine commensal and virulence phenotypes[...]

Preexposure Prophylaxis for HIV: Updated Recommendations From the 2024 International Antiviral Society-USA Panel

Landovitz RJ, Molina JM, Buchbinder SP; International Antiviral Society-USA (IAS-USA) Panel. Preexposure Prophylaxis for HIV: Updated Recommendations From the 2024 International Antiviral Society-USA Panel. JAMA.[...]